| PK_1cmt |
One compartment PK model with linear clearance |
| PK_1cmt_des |
One compartment PK model with linear clearance using
differential equations |
| PK_2cmt |
Two compartment PK model with linear clearance |
| PK_2cmt_des |
Two compartment PK model with linear clearance using
differential equations |
| PK_2cmt_no_depot |
Two compartment PK model with linear clearance using
differential equations |
| PK_2cmt_tdcl_des |
Two compartment PK model with time-dependent clearance
using differential equations (structured like nivolumab PK model) |
| PK_3cmt |
Three compartment PK model with linear clearance |
| PK_3cmt_des |
Three compartment PK model with linear clearance using
differential equations |
| phenylalanine_charbonneau_2021 |
Phenylalanine model for absorption and metabolism in
healthy subjects and patients with PKU |
| indirect_0cpt_transitEx |
Two compartment PK model with Michealis-Menten
clearance using differential equations |
| indirect_1cpt_inhi_kin |
One compartment indirect response model with inhibition
of kin. |
| indirect_1cpt_inhi_kin_CLV |
One compartment indirect response model with inhibition
of kin. |
| indirect_1cpt_inhi_kin_r0rmaxcrmax |
One compartment indirect response model with inhibition
of kin. |
| indirect_1cpt_inhi_kout |
One compartment indirect response model with inhibition
of kout. |
| indirect_1cpt_inhi_kout_CLV |
One compartment indirect response model with inhibition
of kout. |
| indirect_1cpt_inhi_kout_r0rmaxcrmax |
One compartment indirect response model with inhibition
of kout. |
| indirect_1cpt_stim_kin |
One compartment indirect response model with
stimulation of kin.Parameterized using rate cosntants |
| indirect_1cpt_stim_kin_CLV |
One compartment indirect response model with
stimulation of kin. |
| indirect_1cpt_stim_kin_r0rmaxcrmax |
One compartment indirect response model with
stimulation of kin. |
| indirect_1cpt_stim_kout |
One compartment indirect response model with
stimulation of kout.Parameterized using rate cosntants |
| indirect_1cpt_stim_kout_CLV |
One compartment indirect response model with
stimulation of kout. |
| indirect_1cpt_stim_kout_r0rmaxcrmax |
One compartment indirect response model with
stimulation of kout. |
| indirect_circ_1cpt_inhi_kin_kin_t |
One compartment indirect response model with inhibition
of kin and circadian kin_t. |
| indirect_circ_1cpt_inhi_kin_kout_t |
One compartment indirect response model with inhibition
of kin and circadian kin_t. |
| indirect_circ_1cpt_inhi_kout_kin_t |
One compartment indirect response model with inhibition
of kout and circadian kin_t. |
| indirect_circ_1cpt_inhi_kout_kout_t |
One compartment indirect response model with inhibition
of kout and circadian kin_t. |
| indirect_circ_1cpt_stim_kin_kin_t |
One compartment indirect response model with
stimulation of kin and circadian kin_t.Parameterized using rate
cosntants |
| indirect_circ_1cpt_stim_kin_kout_t |
One compartment indirect response model with
stimulation of kin and circadian kout_t.Parameterized using rate
constants |
| indirect_circ_1cpt_stim_kout_kin_t |
One compartment indirect response model with
stimulation of kout and circadian kin_t.Parameterized using rate
cosntants |
| indirect_circ_1cpt_stim_kout_kout_t |
One compartment indirect response model with
stimulation of kout and circadian kout_t.Parameterized using rate
cosntants |
| indirect_prec_1cpt_inhi_CLV |
One compartment precursor-dependent indirect response
model with inhibition of drug response. Parameterized with clearance and
volume. (effect). |
| indirect_prec_1cpt_inhi_r0rmaxcrmax |
One compartment precursor-dependent indirect response
model with inhibition of drug response (effect). |
| indirect_prec_1cpt_stim_CLV |
One compartment precursor-dependent indirect response
model with inhibition of drug response (effect). Parameterized with
clearance and volume |
| indirect_prec_1cpt_stim_r0rmaxcrmax |
One compartment precursor-dependent indirect response
model with inhibition of drug response (effect). Parameterized with
clearance and volume |
| PK_2cmt_mAb_Davda_2014 |
Two compartment PK model with linear clearance for
average monoclonal antibodies (Davda 2014) |
| PK_double_sim_01 |
PK double absorption model with simultaneous zero order
and first order absorptions |
| PK_double_sim_10 |
PK double absorption model with simultaneous first
order and zero order absorptions |
| PK_double_sim_11 |
PK double absorption model with simultaneous first
order absorptions |
| CarlssonPetri_2021_liraglutide |
Liraglutide PK model in adolescents (Carlsson Petri
2021) |
| Cirincione_2017_exenatide |
Exenatide immediate-release PK model (Cirincione
2017) |
| Grimm_2023_gantenerumab |
Gantenerumab PK model (Grimm 2017) |
| Grimm_2023_trontinemab |
Trontinemab PK model (Grimm 2017) |
| Kovalenko_2020_dupilumab |
Dupilumab PK model (Kovalenko 2020) |
| Kyhl_2016_nalmefene |
NA |
| Soehoel_2022_tralokinumab |
Tralokinumab PK model (Soehoel 2022) |
| Zhu_2017_lebrikizumab |
Lebrikizumab PK model (Zhu 2017) |
| oncology_sdm_lobo_2002 |
Signal transduction model for delayed concentration
effects on cancer cell growth |
| oncology_xenograft_simeoni_2004 |
Oncology tumor growth model in xenograft models |
| tgi_no_sat_Koch |
One compartment TGI model with with exponential tumor
growth, without saturation. |
| tgi_no_sat_expo |
One compartment TGI model with with exponential tumor
growth, without saturation. |
| tgi_no_sat_linear |
One compartment TGI model with with linear tumor
growth, without saturation. |
| tgi_no_sat_powerLaw |
One compartment TGI model with with exponential tumor
growth, without saturation. |
| tgi_sat_VonBertalanffy |
One compartment TGI model where tumor growth is limited
by a loss term, with saturation. |
| tgi_sat_genVonBertalanffy |
One compartment TGI model where tumor growth is limited
by a loss term, with saturation. |
| tgi_sat_logistic |
One compartment TGI model with with exponential tumor
growth that decelerates linearly, with saturation. |